You are here: Scientific Experts > Finland > Helsinki University Central Hospital > Appelberg > B G Appelberg

Research Topics buspirone citalopram patient dropouts fluoxetine serotonin agonists placebos serotonin uptake inhibitors single blind method finland ambulatory care depressive disorder psychiatric status rating scales drug administration schedule combination drug therapy double blind method severity of illness index

B G Appelberg Summary Affiliation: Helsinki University Central Hospital Country: Finland Publications Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study B G Appelberg Department of Psychiatry, University of Helsinki, Finland J Clin Psychiatry 62:448-52. 2001

 

Credits   | Contact Us  |  Privacy Notice  |  Disclaimer  |  FAQ

Labome.Org © 2013 All Rights Researved
Princeton, New Jersey 08540, USA